Navigation Links
R-Tech Ueno Notifies R&D Items
Date:7/30/2009

TOKYO, July 31 /PRNewswire/ -- R-Tech Ueno, Ltd. announced on July 29 after discussing its R&D policy at a meeting of the board of directors held on the day and determined the R&D items as follows.

The company intends to actively strengthen R&D in the ophthalmologic & dermatological fields that are its priority and exclusive areas, and promote relevant affiliation, etc. with external entities.

1. Development code UF-021 (eye diseases)

The item in question is isopropyl unoproston, the effective ingredient of "Rescula(R) eyedrop 0.12%" that is marketed as a therapeutic drug for glaucoma and ocular hypertension. This drug is now being developed by R-Tech Ueno for the indication of retinitis pigmentosa. The drug is introduced to Sucampo Pharma Americas Ltd. in the USA to be developed for the indication of atrophic age-related macular degeneration.

2. Development code RTU-007 (eye diseases)

The license is obtained from Astellas Pharma Inc. for the substance to inhibit the enzyme that increases in patients with diabetes mellitus. We intend to proceed with the development of this substance to be indicated for diabetic cataract, diabetic retinopathy and age-related macular degeneration.

3. Development code RU-10 (eye diseases)

Dry eye is targeted for development of the drug that contains gene recombination human serum albumin as an effective ingredient. Though the clinical study is currently interrupted, we intend to look for overseas affiliation soon because the need for treatment of dry eye is globally unmet (that is, there are currently few therapeutic drugs).

4. Development code RK-023 (dermatological diseases)

This item is a physiologically active fatty acid derivative that is a new compound developed by R-Tech Ueno and is being developed as a drug indicated for male
'/>"/>

SOURCE R-Tech Ueno, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
2. AMEX Notifies Signalife That It Has Accepted Signalifes Plan of Compliance
3. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
4. Boston Scientific Announces First Quarter Special Items
5. Arpida Announces Agenda Items for Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... DIEGO , June 30, 2015  The ... Education in Biosciences (CCE/Bio) and UC San Diego ... fermentation, to be held Aug.  12 – 14, ... ).  This three-day workshop provides an intense exposure ... industrial biotechnology, and is well-suited to biologists, process ...
(Date:6/30/2015)... , June 30, 2015  The Dr. Samadi Prostate ... is now offering a full suite of new genetic testing ... a biopsy, for diagnosing prostate cancer. ... of genetic tests for assessing the risk and optimizing the ... "We,re very excited to now offer these revolutionary genetic ...
(Date:6/30/2015)... ... 30, 2015 , ... Cannavoices , Inc., a premier ... video and broadcast initiative. Produced by filmmakers, the multi-platform initiative aims to become ... cannabis stories ever assembled. , Cannavoices profiles Advocates, Patients, Entrepreneurs, Growers, Investors, ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Under the terms of the agreement, MediVet will acquire the rights to a ... MB-007 is currently in pre-clinical development as a potential next-generation treatment for various ...
Breaking Biology Technology:UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 4New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 5Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3
... SUNNYVALE, Calif., Feb. 6 Cepheid (Nasdaq:,CPHD) will ... full year,2007 after the markets close on Thursday, ... a live conference call and webcast that afternoon ... ), John Bishop, Chief Executive Officer, and ...
... SGXP ) announced today that the Company will be presenting ... -- 10th Annual BIO CEO & Investor Conference: Wednesday, February ... Time at the Waldorf=Astoria, New York City. -- Roth 20th ... at 11:30 AM Pacific Standard Time at the Ritz ...
... A new generation of sensors for detecting explosives and ... of radiation known as,T-rays, published today (3 February) in ... T-rays, electromagnetic waves in the far,infrared part of the ... visible light, can be guided along the surface of ...
Cached Biology Technology:Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 2'T-ray' breakthrough signals next generation of security sensors 2
(Date:6/30/2015)... -- Genisphere announced Tom Bliss ... develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss comes ... of the last 25 years in leadership positions at ... & Johnson. Tom started his career in Investment Banking, ... He graduated from Dartmouth College with a BA in ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/24/2015)... The biologics safety testing market is growing ... market include growth of the pharmaceutical and biological industries ... the years, the number of drug approvals in North ... FDA approved 225 drug applications and Health Canada approved ... accounted for 3,822 of the pharmaceutical and ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... SALT LAKE CITY, Nov. 15, 2012 ActiveCare, ... and diabetes management solutions, announced a dramatic decrease in ... relationship with Caprock HealthPlans. ActiveCare,s revolutionary health monitoring and ... specialists has lead to a healthier Caprock. By collecting ...
... available in Spanish . , Artificial logs that ... made from a perhaps surprising source: grass clippings. ... chemist Syed H. Imam and his colleagues have shown that lawn ... fire logs that burn brightly and evenly. The same formula can ...
... streams begins to occur at the initial stages of urban ... study found that streams are more sensitive to development than ... as fragile organisms, and yet that is exactly what the ... said USGS Director Marcia McNutt. "Streams are more than water, ...
Cached Biology News:Diabetes Management Provider ActiveCare Announces Cost Savings Of Over $4,000 Per Year Per Diabetic Member 2Fire logs made from lawn clippings offer earth-friendly option 2Streams show signs of degradation at earliest stages of urban development 2
Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
Human SOST Affinity Purified Polyclonal Ab...
BOND ELUT MATRIX-C18, 25 mg ...
Prepared from plasminogen by activation with immobilized human uPA...
Biology Products: